SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001062993-24-017455
Filing Date
2024-10-07
Accepted
2024-10-07 16:05:14
Documents
15
Period of Report
2024-10-02
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm   iXBRL 8-K 17351
  Complete submission text file 0001062993-24-017455.txt   229053

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT igxt-20241002.xsd EX-101.SCH 4469
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT igxt-20241002_cal.xml EX-101.CAL 694
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT igxt-20241002_def.xml EX-101.DEF 22200
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT igxt-20241002_lab.xml EX-101.LAB 46376
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT igxt-20241002_pre.xml EX-101.PRE 24829
18 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 2956
Mailing Address 6420 ABRAMS SAINT LAURENT A8 H4S 1Y2
Business Address 6420 ABRAMS SAINT LAURENT A8 H4S 1Y2 514-331-7440
IntelGenx Technologies Corp. (Filer) CIK: 0001098880 (see all company filings)

IRS No.: 870638336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31187 | Film No.: 241357831
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)